Navigation Links
China Medicine to Present at CCG IR's China Rising Conference in New York
Date:5/5/2009

GUANGZHOU, China, May 5 /PRNewswire-Asia-FirstCall/ -- China Medicine Corporation (OTC Bulletin Board: CHME) ("China Medicine" or "the Company"), a leading distributor and developer of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines ("TCM"), nutritional and dietary-supplements, medical devices, and medical formulations in the People's Republic of China ("PRC"), announced today that the Company's management will present at the upcoming China Rising Conference hosted by CCG Investor Relations in New York, NY on May 18, 2009.

The date, time and location of China Medicine's presentation at the China Rising Conference are as follows:

    Date:           Monday, May 18, 2009
    Time:           1:30 p.m. to 2:00 p.m. Eastern Time
    Presenter:      Mr. Senshan Yang, Chief Executive Officer
                    Ms. Minhua Liu, Executive Vice President
                    Ms. Gavin Chen, CFO Assistant
    Venue:          The Yale Club
                    50 Vanderbilt Avenue
                    New York, NY 10017
    Webcast:       http://www.chinarisingconference.com/webcast.html

A replay of the webcast will be available for up to one year following the presentation using the same link.

The China Rising Investment Conference hosted by CCG Investor Relations will provide over 250 fund managers and investors access to senior management of a wide range of Chinese growth companies in sectors including consumer staples, agriculture, pharmaceuticals, infrastructure, information technology, advanced materials, capital goods, and alternative energy. The conference will include over 30 US-listed Chinese companies and a number of private companies.

Interested parties and investors may find more information for the conference by visiting the website at http://www.chinarisingconference.com.

About China Medicine Corporation

China Medicine Corporation is a developer and leading distributor of prescription and over the counter ("OTC") drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. China Medicine also has its research and development force for certain products it manufactures through OEM arrangement makes the distribution. The Company distributes its products to wholesale distributors including more than 300 hospitals and 500 medicine companies that sell to over 2,000 drug stores in 28 provinces throughout China. The Company actively develops a number of proprietary products for a variety of uses, including oncology, high blood pressure and the removal of toxins from food and animal feeds. For more information visit the Company's website at http://www.chinamedicinecorp.com

Cautionary Statement

This press release contains forward-looking statements concerning the Company's business and products. The Company's actual results may differ materially depending on a number of risk factors including, but not limited to, the following: general economic and business conditions, obtaining regulatory approval for new products, the expected contribution of higher margin products, government support for rural health care, competition from existing and new competitors, changes in technology, and various other factors beyond its control. All forward-looking statements are expressly qualified in their entirety by this Cautionary Statement and the risks factors detailed in the Company's reports filed with the Securities and Exchange Commission. China Medicine Corporation undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

    Company Contact:                 Investor Relations Contact:
    Ms. Huizhen Yu                   Mr. Crocker Coulson, President
    Chief Financial Officer          CCG Investor Relations
    China Medicine Corp              Tel: +1-646-213-1915 (NY Office)
    Tel: +86-20-8739-1718            E-mail: crocker.coulson@ccgir.com
    E-mail: konzern08@163.com        Website: www.ccgirasia.com


'/>"/>
SOURCE China Medicine Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. IBM Announces New Healthcare Industry Solutions Lab in China
2. Solta Medical Receives Regulatory Approval to Market Thermage Systems in China
3. China Pharma Holdings, Inc. Retains Global Investor Communications Team
4. goBalto Partners With ChinaBio to Expand Its List of Contract Research Organizations
5. China Pharma Holdings, Inc. Appoints Chief Financial Officer and Board Member
6. Milestone Scientific Grants Sinopharm Exclusive Distribution and Marketing Rights to STA System in China
7. NIAID and Chinese officials sign agreement to foster TB research in Chinas Henan province
8. China Seeks to Transform Healthcare Sector with Information Technology
9. China Medicine Corporation Achieves Major Milestone for rADTZ
10. Majority of doctors skeptical of organ transplantation practices in China
11. A Message to Investors from China Sky One Medical, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... Researchers can ... so routine. A fresh look at this technique may yield big benefits. Scientists ... reproducibility of experiments in a cell culture laboratory—and lessen the risk of contamination ...
(Date:5/23/2016)... ... May 23, 2016 , ... In light of ... reminds pet owners that intervening at the first sign of their pet overheating ... normal body mechanisms cannot keep the body’s temperature within a safe range. Considered ...
(Date:5/23/2016)... ... May 23, 2016 , ... The Society for Women’s Health ... to move on from that role. , “No one in Washington led the way ... said SWHR Founder Florence Haseltine, MD, PhD. “We offer our deep gratitude to Phyllis ...
(Date:5/23/2016)... ... 2016 , ... Hadley Institute for the Blind and Visually ... or visually impaired, announces the election of Julie S. Tye as its next ... of Trustees retained Morris & Berger, a firm specializing in non-profit executive searches, ...
(Date:5/23/2016)... NY (PRWEB) , ... May 23, 2016 , ... ... the company’s top management team to meet the needs of its recent and ... to drive continued growth and business development across widening market segments. Max joined ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... 23, 2016 Gamida Cell, a ... of cancer and orphan genetic diseases, announced today it ... million from the Israel Innovation Authority (formerly the Office ... Economy and Industry. The mission of the Israel Innovation ... industries, including science and technology, while stimulating economic growth. ...
(Date:5/22/2016)... 2016 DS Biopharma (DS) ... anti-inflammatory compound DS102 in chronic obstructive pulmonary disease ... (NASH) patients. Recent DS preclinical data ... tissue and has bronchodilatory, anti-inflammatory and anti-fibrotic properties ... Company will publish further detail on these findings ...
(Date:5/20/2016)... 2016 - Revenue Forecasts ... Growth Hormones, Recombinant Coagulation Factors and Regenerative Medicine ... New Study Reveals Selling Opportunities and Revenue Prospects ... ,What is the future of biologics, especially new ... commercial analysis. Staying ahead in data and knowledge, ...
Breaking Medicine Technology: